Meanwhile, rates of transverse myelitis were rare. However, researchers did observe higher rates of Bell's palsy, encephalomyelitis, and Guillain-Barré syndrome in survivors of COVID-19.

Genzyme Corp. (Sanofi Genzyme) has divulged emopamil-binding protein (EBP) inhibitors reported to be useful for the treatment of multiple sclerosis, transverse myelitis, neuromyelitis optica, optic ...